Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Contract Research Organization (CRO) and CDMO for Pharmaceutical is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period. The research provides insights for the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Contract Research Organization (CRO) and CDMO for Pharmaceutical industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Segmentations:

    By Players:

    • Medpace Holdings, Inc.

    • ICON PLC

    • EVOTEC AG

    • Pharmaceutical Product Development Inc

    • PAREXEL International Corporation

    • WuXi AppTec

    • PRA HEALTH SCIENCES, INC.

    • Envigo

    • SGS SA

    • IQVIA HOLDINGS INC.

    • Charles River Laboratories, Inc.

    • Laboratory Corporation of America Holdings (LABCORP)

    • Eurofins Scientific

    • EPS INTERNATIONAL

    • Syneos Health Inc

    • GenScript Biotech Corporation

    By Types:

    • Protein Production & Purification Service

    • Antibody Production & Development Service

    • Transient Transfection CRO Service

    • Molecular Biology Service

    By End-User:

    • Pharmaceutical and Biopharmaceutical Companies

    • Academic Institutes

    • Research Institutes

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Contract Research Organization (CRO) and CDMO for Pharmaceutical Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Types

      • 1.3.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Protein Production & Purification Service from 2014 to 2026

      • 1.3.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Antibody Production & Development Service from 2014 to 2026

      • 1.3.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Transient Transfection CRO Service from 2014 to 2026

      • 1.3.5 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Molecular Biology Service from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by End-Users

      • 1.4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Pharmaceutical and Biopharmaceutical Companies from 2014 to 2026

      • 1.4.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Academic Institutes from 2014 to 2026

      • 1.4.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Contract Research Organization (CRO) and CDMO for Pharmaceutical Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Major Types

      • 3.4.1 Market Size and Growth Rate of Protein Production & Purification Service

      • 3.4.2 Market Size and Growth Rate of Antibody Production & Development Service

      • 3.4.3 Market Size and Growth Rate of Transient Transfection CRO Service

      • 3.4.4 Market Size and Growth Rate of Molecular Biology Service

    4 Segmentation of Contract Research Organization (CRO) and CDMO for Pharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Contract Research Organization (CRO) and CDMO for Pharmaceutical for Pharmaceutical and Biopharmaceutical Companies

      • 4.4.2 Market Size and Growth Rate of Contract Research Organization (CRO) and CDMO for Pharmaceutical for Academic Institutes

      • 4.4.3 Market Size and Growth Rate of Contract Research Organization (CRO) and CDMO for Pharmaceutical for Research Institutes

    5 Market Analysis by Major Regions

    • 5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Analysis by Major Regions

    • 5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Analysis by Major Regions

    • 5.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis

    6 Product Commodity of Contract Research Organization (CRO) and CDMO for Pharmaceutical Market in Major Countries

    • 6.1 Top 5 Export Countries in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis

    • 7.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major Types

    • 7.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major End-Users

    • 7.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major Countries

      • 7.3.1 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 7.3.2 Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 7.3.3 Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

    8 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis

    • 8.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major Types

    • 8.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major End-Users

    • 8.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major Countries

      • 8.3.1 Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.2 UK Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.3 France Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.4 Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.6 Spain Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.7 Belgium Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.8 Poland Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.9 Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 8.3.10 Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

    9 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis

    • 9.1 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major Types

    • 9.2 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major Countries

      • 9.3.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 9.3.2 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 9.3.4 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 9.3.6 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 10.3.2 Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 10.3.3 Nigeria Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

      • 10.3.4 South Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate 

      • 10.3.5 Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Medpace Holdings, Inc.

      • 11.1.1 Medpace Holdings, Inc. Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 ICON PLC

      • 11.2.1 ICON PLC Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 EVOTEC AG

      • 11.3.1 EVOTEC AG Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Pharmaceutical Product Development Inc

      • 11.4.1 Pharmaceutical Product Development Inc Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 PAREXEL International Corporation

      • 11.5.1 PAREXEL International Corporation Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 WuXi AppTec

      • 11.6.1 WuXi AppTec Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 PRA HEALTH SCIENCES, INC.

      • 11.7.1 PRA HEALTH SCIENCES, INC. Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Envigo

      • 11.8.1 Envigo Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 SGS SA

      • 11.9.1 SGS SA Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 IQVIA HOLDINGS INC.

      • 11.10.1 IQVIA HOLDINGS INC. Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Charles River Laboratories, Inc.

      • 11.11.1 Charles River Laboratories, Inc. Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Laboratory Corporation of America Holdings (LABCORP)

      • 11.12.1 Laboratory Corporation of America Holdings (LABCORP) Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Eurofins Scientific

      • 11.13.1 Eurofins Scientific Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 EPS INTERNATIONAL

      • 11.14.1 EPS INTERNATIONAL Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Syneos Health Inc

      • 11.15.1 Syneos Health Inc Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 GenScript Biotech Corporation

      • 11.16.1 GenScript Biotech Corporation Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 86 Figures and 150 Tables)

    • Figure Product Picture

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Protein Production & Purification Service from 2014 to 2026

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Antibody Production & Development Service from 2014 to 2026

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Transient Transfection CRO Service from 2014 to 2026

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Molecular Biology Service from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Pharmaceutical and Biopharmaceutical Companies from 2014 to 2026

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Academic Institutes from 2014 to 2026

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Contract Research Organization (CRO) and CDMO for Pharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Different Types from 2014 to 2026

    • Table Consumption Share of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Protein Production & Purification Service

    • Figure Market Size and Growth Rate of Antibody Production & Development Service

    • Figure Market Size and Growth Rate of Transient Transfection CRO Service

    • Figure Market Size and Growth Rate of Molecular Biology Service

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Different End-Users from 2014 to 2026

    • Table Consumption Share of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pharmaceutical and Biopharmaceutical Companies

    • Figure Market Size and Growth Rate of Academic Institutes

    • Figure Market Size and Growth Rate of Research Institutes

    • Table Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production by Major Regions

    • Table Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Share by Major Regions

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Share by Major Regions in 2014

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Share by Major Regions in 2018

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Share by Major Regions in 2026

    • Table Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Major Regions

    • Table Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Regions

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Regions in 2014

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Regions in 2018

    • Figure Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Regions in 2026

    • Table North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Types from 2014 to 2026

    • Table North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2014

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2018

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2026

    • Table North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2014

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2018

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2026

    • Table North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2014

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2018

    • Figure North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2026

    • Figure United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2014

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2018

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2026

    • Table Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2014

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2018

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2026

    • Table Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2014

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2018

    • Figure Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2026

    • Figure Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure France Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2014

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2018

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2026

    • Table Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2014

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2018

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2026

    • Table Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2026

    • Figure China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandContract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Share by Major Countries in 2026

    • Figure GCC Countries Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Medpace Holdings, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medpace Holdings, Inc.

    • Figure Sales and Growth Rate Analysis of Medpace Holdings, Inc.

    • Figure Revenue and Market Share Analysis of Medpace Holdings, Inc.

    • Table Product and Service Introduction of Medpace Holdings, Inc.

    • Table Company Profile and Development Status of ICON PLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ICON PLC

    • Figure Sales and Growth Rate Analysis of ICON PLC

    • Figure Revenue and Market Share Analysis of ICON PLC

    • Table Product and Service Introduction of ICON PLC

    • Table Company Profile and Development Status of EVOTEC AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EVOTEC AG

    • Figure Sales and Growth Rate Analysis of EVOTEC AG

    • Figure Revenue and Market Share Analysis of EVOTEC AG

    • Table Product and Service Introduction of EVOTEC AG

    • Table Company Profile and Development Status of Pharmaceutical Product Development Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmaceutical Product Development Inc

    • Figure Sales and Growth Rate Analysis of Pharmaceutical Product Development Inc

    • Figure Revenue and Market Share Analysis of Pharmaceutical Product Development Inc

    • Table Product and Service Introduction of Pharmaceutical Product Development Inc

    • Table Company Profile and Development Status of PAREXEL International Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PAREXEL International Corporation

    • Figure Sales and Growth Rate Analysis of PAREXEL International Corporation

    • Figure Revenue and Market Share Analysis of PAREXEL International Corporation

    • Table Product and Service Introduction of PAREXEL International Corporation

    • Table Company Profile and Development Status of WuXi AppTec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of WuXi AppTec

    • Figure Sales and Growth Rate Analysis of WuXi AppTec

    • Figure Revenue and Market Share Analysis of WuXi AppTec

    • Table Product and Service Introduction of WuXi AppTec

    • Table Company Profile and Development Status of PRA HEALTH SCIENCES, INC.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PRA HEALTH SCIENCES, INC.

    • Figure Sales and Growth Rate Analysis of PRA HEALTH SCIENCES, INC.

    • Figure Revenue and Market Share Analysis of PRA HEALTH SCIENCES, INC.

    • Table Product and Service Introduction of PRA HEALTH SCIENCES, INC.

    • Table Company Profile and Development Status of Envigo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Envigo

    • Figure Sales and Growth Rate Analysis of Envigo

    • Figure Revenue and Market Share Analysis of Envigo

    • Table Product and Service Introduction of Envigo

    • Table Company Profile and Development Status of SGS SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SGS SA

    • Figure Sales and Growth Rate Analysis of SGS SA

    • Figure Revenue and Market Share Analysis of SGS SA

    • Table Product and Service Introduction of SGS SA

    • Table Company Profile and Development Status of IQVIA HOLDINGS INC.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IQVIA HOLDINGS INC.

    • Figure Sales and Growth Rate Analysis of IQVIA HOLDINGS INC.

    • Figure Revenue and Market Share Analysis of IQVIA HOLDINGS INC.

    • Table Product and Service Introduction of IQVIA HOLDINGS INC.

    • Table Company Profile and Development Status of Charles River Laboratories, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Charles River Laboratories, Inc.

    • Figure Sales and Growth Rate Analysis of Charles River Laboratories, Inc.

    • Figure Revenue and Market Share Analysis of Charles River Laboratories, Inc.

    • Table Product and Service Introduction of Charles River Laboratories, Inc.

    • Table Company Profile and Development Status of Laboratory Corporation of America Holdings (LABCORP)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Laboratory Corporation of America Holdings (LABCORP)

    • Figure Sales and Growth Rate Analysis of Laboratory Corporation of America Holdings (LABCORP)

    • Figure Revenue and Market Share Analysis of Laboratory Corporation of America Holdings (LABCORP)

    • Table Product and Service Introduction of Laboratory Corporation of America Holdings (LABCORP)

    • Table Company Profile and Development Status of Eurofins Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eurofins Scientific

    • Figure Sales and Growth Rate Analysis of Eurofins Scientific

    • Figure Revenue and Market Share Analysis of Eurofins Scientific

    • Table Product and Service Introduction of Eurofins Scientific

    • Table Company Profile and Development Status of EPS INTERNATIONAL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EPS INTERNATIONAL

    • Figure Sales and Growth Rate Analysis of EPS INTERNATIONAL

    • Figure Revenue and Market Share Analysis of EPS INTERNATIONAL

    • Table Product and Service Introduction of EPS INTERNATIONAL

    • Table Company Profile and Development Status of Syneos Health Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Syneos Health Inc

    • Figure Sales and Growth Rate Analysis of Syneos Health Inc

    • Figure Revenue and Market Share Analysis of Syneos Health Inc

    • Table Product and Service Introduction of Syneos Health Inc

    • Table Company Profile and Development Status of GenScript Biotech Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GenScript Biotech Corporation

    • Figure Sales and Growth Rate Analysis of GenScript Biotech Corporation

    • Figure Revenue and Market Share Analysis of GenScript Biotech Corporation

    • Table Product and Service Introduction of GenScript Biotech Corporation


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.